Studies have found a potential link between the drug Dupixent and an increased risk of cancer. There are reports of lawsuits being filed over cancer concerns, including allegations of a connection to T-cell lymphoma. However, the nature and extent of the risk are not entirely clear, with one report also mentioning a link to psoriasis, a different condition.